Edluar is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Meda Pharmaceuticals. The primary component is Zolpidem Tartrate.
Product ID | 0037-6050_2ba4ee31-fd16-45e7-bedb-68770a0bc5c8 |
NDC | 0037-6050 |
Product Type | Human Prescription Drug |
Proprietary Name | Edluar |
Generic Name | Zolpidem Tartrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2009-07-24 |
Marketing Category | NDA / NDA |
Application Number | NDA021997 |
Labeler Name | Meda Pharmaceuticals |
Substance Name | ZOLPIDEM TARTRATE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [CS],Central Nervous System Depression [PE] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2009-07-24 |
Marketing End Date | 2023-01-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021997 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-07-24 |
Ingredient | Strength |
---|---|
ZOLPIDEM TARTRATE | 5 mg/1 |
SPL SET ID: | a32884d0-85b5-11de-8a39-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0037-6010 | Edluar | Zolpidem Tartrate |
0037-6050 | Edluar | Zolpidem Tartrate |
0024-5401 | Ambien | zolpidem tartrate |
0024-5421 | Ambien | zolpidem tartrate |
0024-5501 | Ambien | zolpidem tartrate |
0024-5521 | Ambien | zolpidem tartrate |
0054-0086 | Zolpidem Tartrate | zolpidem tartrate |
0054-0087 | Zolpidem Tartrate | zolpidem tartrate |
0093-0073 | Zolpidem Tartrate | Zolpidem Tartrate |
0093-0074 | Zolpidem Tartrate | Zolpidem Tartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EDLUAR 87946702 5669354 Live/Registered |
Meda Pharmaceuticals Inc. 2018-06-04 |
EDLUAR 77557224 4045758 Dead/Cancelled |
Meda Pharmaceuticals Inc. 2008-08-27 |